You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH):子公司獲得2項發明專利證書
格隆匯 07-06 15:51

格隆匯7月6日丨珍寶島(603567.SH)公佈,近日,公司子公司哈爾濱珍寶製藥有限公司分別收到美國和韓國專利局頒發的《專利授權證書》,發明名稱:作為Akt抑制劑的鹽型及其晶型;作為Akt抑制劑的鹽型及其晶型。

Akt(蛋白激酶B,在細胞存活和凋亡中起重要作用)抑制劑的臨牀研究表明在多種惡性腫瘤治療的過程中,靶向作用的抗腫瘤效果較好。Akt抑制劑的鹽型及其晶型信號通路通過激活NF-kB促生存信號和抑制JNK/p38凋亡信號相互聯繫相互影響,使其對治療抗腫瘤、類風濕性關節炎等疾病起重要的作用,具有較高的臨牀價值。其不僅有助於發揮生物藥劑學的特性,還可以為原料藥和製劑的開發創造技術性條件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account